Menu

Blog

Apr 28, 2024

Study identifies driver of liver cancer that could be target for treatment

Posted by in categories: biotech/medical, futurism

In a new study, a Yale Pathology team has identified a possible therapeutic target for treating obesity-induced liver cancer.

Researchers say inhibiting a molecule called fatty acid binding protein 5 (FABP5) could block tumor progression in many cases:


Inhibiting a certain protein in mice reduced obesity-induced liver tumor development, Yale researchers found. It could reveal a future treatment route.

Comments are closed.